A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma

Inclusion Criteria: * Patients with malignant renal tumours must have postoperative pathological confirmation of renal clear cell carcinoma with pathological TNM stage Ⅰ-Ⅲ; * Have available preoperative imaging * Have available post-operative pathological paraffin samples or HE-stained tissue sections * Must agree to and be able to comply with the study's visit schedule and other requirements as specified in the protocol, including follow-up visits by telephone Exclusion Criteria: * The patient's tumour type cannot be determined on the basis of histopathological sections * Simultaneous combination of primary tumours at other sites; * No regular follow-up imaging data * Cases in which other factors led the investigator to believe that enrolment was inappropriate * Cases that met all the inclusion criteria of the appeal and did not meet all the exclusion criteria were selected for this study